Grove, Inc. (GRVI)

$4.95

+0.35 (+7.61%)
Rating:
Recommendation:
-
Symbol GRVI
Price $4.95
Beta 0.000
Volume Avg. 0.06M
Market Cap 83.258M
Shares () -
52 Week Range 3.76-9.36
1y Target Est -
DCF Unlevered GRVI DCF ->
DCF Levered GRVI LDCF ->
ROE 12.48% Buy
ROA 9.78% Neutral
Operating Margin -
Debt / Equity 16.67% Neutral
P/E 26.05 Strong Buy
P/B 2.86 Strong Buy
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades

Latest GRVI news


Mr. Allan J. Marshall
Healthcare
Drug Manufacturers—Specialty & Generic
NASDAQ Capital Market

Grove, Inc., through its subsidiaries, engages in developing, producing, marketing, and selling raw materials, white label products, and end consumer products containing the industrial hemp plant extract, cannabidiol. The company serves consumer markets, including the botanical, beauty care, pet care, and functional food sectors. It also operates annual tradeshow related to the CBD industry in the United States. The company was incorporated in 2018 and is headquartered in Henderson, Nevada.